Indivior

News

Indivior stung by fraud charges over US marketing

Shares in UK drugmaker Indivior have gone into freefall after it was charged by the US Department of Justice for fraudulently marketing its opioid addiction treatment.

Debates & Insight

Ensuring delivery of healthcare professional education

Pharma companies always need to know they can get the right information to the right people at the right time.

News

Indivior hit hard as generic Suboxone defence crumbles

Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the door to generic competition and sparking a run on its shares.

News

Indivior's once-monthly schizophrenia injection gets US gree...

Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia.

Indivior stung by fraud charges over US marketing

Ensuring delivery of healthcare professional education

Indivior hit hard as generic Suboxone defence crumbles

Indivior's once-monthly schizophrenia injection gets US gree...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Indivior

Editor's Picks